Publication Information

{'id': 'https://openalex.org/W2893570865', 'doi': 'https://doi.org/10.1111/bjh.15566', 'title': 'Patient and physician preferences for first‐line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom', 'display_name': 'Patient and physician preferences for first‐line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom', 'publication_year': 2018, 'publication_date': '2018-09-21', 'ids': {'openalex': 'https://openalex.org/W2893570865', 'doi': 'https://doi.org/10.1111/bjh.15566', 'mag': '2893570865', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/30239982', 'pmcid': 'https://www.ncbi.nlm.nih.gov/pmc/articles/6585631'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/bjh.15566', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.15566', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.15566', 'any_repository_has_fulltext': True}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5061291419', 'display_name': 'Paul J. Bröckelmann', 'orcid': 'https://orcid.org/0000-0001-9662-9900'}, 'institutions': [{'id': 'https://openalex.org/I4210153755', 'display_name': 'University Hospital Cologne', 'ror': 'https://ror.org/05mxhda18', 'country_code': 'DE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210153755']}], 'countries': ['DE'], 'is_corresponding': True, 'raw_author_name': 'Paul J. Bröckelmann', 'raw_affiliation_strings': ['Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany'], 'affiliations': [{'raw_affiliation_string': 'Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany', 'institution_ids': ['https://openalex.org/I4210153755']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028058160', 'display_name': 'Suzanne McMullen', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Suzanne McMullen', 'raw_affiliation_strings': ['Epidemiology, ICON plc, Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Epidemiology, ICON plc, Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022370444', 'display_name': 'Jake Wilson', 'orcid': None}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'J Ben Wilson', 'raw_affiliation_strings': ['Epidemiology, ICON plc, Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Epidemiology, ICON plc, Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071986795', 'display_name': 'Kerstin Mueller', 'orcid': 'https://orcid.org/0000-0003-3315-4674'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Kerstin Mueller', 'raw_affiliation_strings': ['Epidemiology, ICON plc, Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Epidemiology, ICON plc, Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091171760', 'display_name': 'Sarah Goring', 'orcid': 'https://orcid.org/0000-0001-8522-9354'}, 'institutions': [], 'countries': ['CA'], 'is_corresponding': False, 'raw_author_name': 'Sarah Goring', 'raw_affiliation_strings': ['Epidemiology, ICON plc, Vancouver, Canada'], 'affiliations': [{'raw_affiliation_string': 'Epidemiology, ICON plc, Vancouver, Canada', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5061006030', 'display_name': 'Aspasia Stamatoullas', 'orcid': 'https://orcid.org/0000-0001-7321-5254'}, 'institutions': [{'id': 'https://openalex.org/I4387152093', 'display_name': 'Centre Henri Becquerel', 'ror': 'https://ror.org/00whhby07', 'country_code': None, 'type': 'facility', 'lineage': ['https://openalex.org/I4210141925', 'https://openalex.org/I4387152093']}], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Aspasia Stamatoullas', 'raw_affiliation_strings': ['Centre Henri Becquerel, Rouen, Cedex, France'], 'affiliations': [{'raw_affiliation_string': 'Centre Henri Becquerel, Rouen, Cedex, France', 'institution_ids': ['https://openalex.org/I4387152093']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023313638', 'display_name': 'Erin Zagadailov', 'orcid': 'https://orcid.org/0000-0002-4903-2762'}, 'institutions': [{'id': 'https://openalex.org/I4210140176', 'display_name': 'Takeda (United States)', 'ror': 'https://ror.org/03bygaq51', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140176', 'https://openalex.org/I44892455']}, {'id': 'https://openalex.org/I4210147799', 'display_name': 'Millennium Engineering and Integration (United States)', 'ror': 'https://ror.org/05qmdfk04', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210147799']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Erin Zagadailov', 'raw_affiliation_strings': ['Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA'], 'affiliations': [{'raw_affiliation_string': 'Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA', 'institution_ids': ['https://openalex.org/I4210140176', 'https://openalex.org/I4210147799']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101778315', 'display_name': 'Ashish Gautam', 'orcid': 'https://orcid.org/0000-0002-9319-7820'}, 'institutions': [{'id': 'https://openalex.org/I4210147799', 'display_name': 'Millennium Engineering and Integration (United States)', 'ror': 'https://ror.org/05qmdfk04', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210147799']}, {'id': 'https://openalex.org/I4210140176', 'display_name': 'Takeda (United States)', 'ror': 'https://ror.org/03bygaq51', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140176', 'https://openalex.org/I44892455']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Ashish Gautam', 'raw_affiliation_strings': ['Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA'], 'affiliations': [{'raw_affiliation_string': 'Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA', 'institution_ids': ['https://openalex.org/I4210147799', 'https://openalex.org/I4210140176']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5111959028', 'display_name': 'Dirk Huebner', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140176', 'display_name': 'Takeda (United States)', 'ror': 'https://ror.org/03bygaq51', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140176', 'https://openalex.org/I44892455']}, {'id': 'https://openalex.org/I4210147799', 'display_name': 'Millennium Engineering and Integration (United States)', 'ror': 'https://ror.org/05qmdfk04', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210147799']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dirk Huebner', 'raw_affiliation_strings': ['Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA'], 'affiliations': [{'raw_affiliation_string': 'Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA', 'institution_ids': ['https://openalex.org/I4210140176', 'https://openalex.org/I4210147799']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045292117', 'display_name': 'Mehul Dalal', 'orcid': 'https://orcid.org/0000-0002-7417-0817'}, 'institutions': [{'id': 'https://openalex.org/I4210140176', 'display_name': 'Takeda (United States)', 'ror': 'https://ror.org/03bygaq51', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210140176', 'https://openalex.org/I44892455']}, {'id': 'https://openalex.org/I4210147799', 'display_name': 'Millennium Engineering and Integration (United States)', 'ror': 'https://ror.org/05qmdfk04', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210147799']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mehul Dalal', 'raw_affiliation_strings': ['Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA'], 'affiliations': [{'raw_affiliation_string': 'Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA', 'institution_ids': ['https://openalex.org/I4210140176', 'https://openalex.org/I4210147799']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5079281059', 'display_name': 'Tim Illidge', 'orcid': 'https://orcid.org/0000-0003-3191-7324'}, 'institutions': [{'id': 'https://openalex.org/I4210131968', 'display_name': 'The Christie Hospital', 'ror': 'https://ror.org/03nd63441', 'country_code': 'GB', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210131968', 'https://openalex.org/I4210133995']}, {'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Tim Illidge', 'raw_affiliation_strings': ['Institute of Cancer Sciences, University of Manchester, Christie Hospital, Manchester, UK'], 'affiliations': [{'raw_affiliation_string': 'Institute of Cancer Sciences, University of Manchester, Christie Hospital, Manchester, UK', 'institution_ids': ['https://openalex.org/I4210131968', 'https://openalex.org/I28407311']}]}], 'institution_assertions': [], 'countries_distinct_count': 4, 'institutions_distinct_count': 6, 'corresponding_author_ids': ['https://openalex.org/A5061291419'], 'corresponding_institution_ids': ['https://openalex.org/I4210153755'], 'apc_list': {'value': 4940, 'currency': 'USD', 'value_usd': 4940, 'provenance': 'doaj'}, 'apc_paid': {'value': 4940, 'currency': 'USD', 'value_usd': 4940, 'provenance': 'doaj'}, 'fwci': 3.324, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 44, 'citation_normalized_percentile': {'value': 0.857548, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 95, 'max': 96}, 'biblio': {'volume': '184', 'issue': '2', 'first_page': '202', 'last_page': '214'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10185', 'display_name': 'Lymphoma Diagnosis and Treatment', 'score': 0.9998, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10183', 'display_name': 'Breast Cancer Treatment Studies', 'score': 0.9529, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T10685', 'display_name': 'Viral-associated cancers and disorders', 'score': 0.935, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/abvd', 'display_name': 'ABVD', 'score': 0.9160428}, {'id': 'https://openalex.org/keywords/dacarbazine', 'display_name': 'Dacarbazine', 'score': 0.90219724}, {'id': 'https://openalex.org/keywords/brentuximab-vedotin', 'display_name': 'Brentuximab vedotin', 'score': 0.8874395}, {'id': 'https://openalex.org/keywords/procarbazine', 'display_name': 'Procarbazine', 'score': 0.87421775}, {'id': 'https://openalex.org/keywords/hodgkins-lymphoma', 'display_name': "Hodgkin's lymphoma", 'score': 0.49447703}], 'concepts': [{'id': 'https://openalex.org/C2776305933', 'wikidata': 'https://www.wikidata.org/wiki/Q287631', 'display_name': 'ABVD', 'level': 5, 'score': 0.9160428}, {'id': 'https://openalex.org/C2780964509', 'wikidata': 'https://www.wikidata.org/wiki/Q416975', 'display_name': 'Dacarbazine', 'level': 3, 'score': 0.90219724}, {'id': 'https://openalex.org/C2778191690', 'wikidata': 'https://www.wikidata.org/wiki/Q422324', 'display_name': 'Brentuximab vedotin', 'level': 4, 'score': 0.8874395}, {'id': 'https://openalex.org/C2779112685', 'wikidata': 'https://www.wikidata.org/wiki/Q418656', 'display_name': 'Procarbazine', 'level': 5, 'score': 0.87421775}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8523655}, {'id': 'https://openalex.org/C2777132456', 'wikidata': 'https://www.wikidata.org/wiki/Q282629', 'display_name': 'Vinblastine', 'level': 3, 'score': 0.6681763}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.57003963}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.5214502}, {'id': 'https://openalex.org/C2776232574', 'wikidata': 'https://www.wikidata.org/wiki/Q415571', 'display_name': 'Bleomycin', 'level': 3, 'score': 0.50406826}, {'id': 'https://openalex.org/C2779020855', 'wikidata': 'https://www.wikidata.org/wiki/Q209369', 'display_name': "Hodgkin's lymphoma", 'level': 3, 'score': 0.49447703}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.48566854}, {'id': 'https://openalex.org/C2779429289', 'wikidata': 'https://www.wikidata.org/wiki/Q408977', 'display_name': 'Vincristine', 'level': 4, 'score': 0.42841485}, {'id': 'https://openalex.org/C2778720950', 'wikidata': 'https://www.wikidata.org/wiki/Q424972', 'display_name': 'Prednisone', 'level': 2, 'score': 0.42460096}, {'id': 'https://openalex.org/C2778119113', 'wikidata': 'https://www.wikidata.org/wiki/Q418817', 'display_name': 'Etoposide', 'level': 3, 'score': 0.4105661}, {'id': 'https://openalex.org/C187212893', 'wikidata': 'https://www.wikidata.org/wiki/Q123028', 'display_name': 'Pediatrics', 'level': 1, 'score': 0.37631553}, {'id': 'https://openalex.org/C2779338263', 'wikidata': 'https://www.wikidata.org/wiki/Q208414', 'display_name': 'Lymphoma', 'level': 2, 'score': 0.3233336}, {'id': 'https://openalex.org/C2776755627', 'wikidata': 'https://www.wikidata.org/wiki/Q408524', 'display_name': 'Cyclophosphamide', 'level': 3, 'score': 0.3191728}, {'id': 'https://openalex.org/C2776694085', 'wikidata': 'https://www.wikidata.org/wiki/Q974135', 'display_name': 'Chemotherapy', 'level': 2, 'score': 0.27796692}, {'id': 'https://openalex.org/C2992779791', 'wikidata': 'https://www.wikidata.org/wiki/Q209369', 'display_name': 'Hodgkin lymphoma', 'level': 3, 'score': 0.26043135}], 'mesh': [{'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D006689', 'descriptor_name': 'Hodgkin Disease', 'qualifier_ui': 'Q000401', 'qualifier_name': 'mortality', 'is_major_topic': True}, {'descriptor_ui': 'D006689', 'descriptor_name': 'Hodgkin Disease', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D057240', 'descriptor_name': 'Patient Preference', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D010818', 'descriptor_name': "Practice Patterns, Physicians'", 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000971', 'descriptor_name': 'Antineoplastic Combined Chemotherapy Protocols', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D001761', 'descriptor_name': 'Bleomycin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D001761', 'descriptor_name': 'Bleomycin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001761', 'descriptor_name': 'Bleomycin', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D003430', 'descriptor_name': 'Cross-Sectional Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003520', 'descriptor_name': 'Cyclophosphamide', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D003520', 'descriptor_name': 'Cyclophosphamide', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D003520', 'descriptor_name': 'Cyclophosphamide', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018572', 'descriptor_name': 'Disease-Free Survival', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D004317', 'descriptor_name': 'Doxorubicin', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005602', 'descriptor_name': 'France', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005602', 'descriptor_name': 'France', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D005858', 'descriptor_name': 'Germany', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005858', 'descriptor_name': 'Germany', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D006689', 'descriptor_name': 'Hodgkin Disease', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011344', 'descriptor_name': 'Procarbazine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D011344', 'descriptor_name': 'Procarbazine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D011344', 'descriptor_name': 'Procarbazine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015996', 'descriptor_name': 'Survival Rate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006113', 'descriptor_name': 'United Kingdom', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006113', 'descriptor_name': 'United Kingdom', 'qualifier_ui': 'Q000453', 'qualifier_name': 'epidemiology', 'is_major_topic': False}, {'descriptor_ui': 'D014747', 'descriptor_name': 'Vinblastine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014747', 'descriptor_name': 'Vinblastine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D014747', 'descriptor_name': 'Vinblastine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D014750', 'descriptor_name': 'Vincristine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014750', 'descriptor_name': 'Vincristine', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': False}, {'descriptor_ui': 'D014750', 'descriptor_name': 'Vincristine', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}], 'locations_count': 4, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/bjh.15566', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.15566', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://europepmc.org/articles/pmc6585631', 'pdf_url': 'https://europepmc.org/articles/pmc6585631?pdf=render', 'source': {'id': 'https://openalex.org/S4306400806', 'display_name': 'Europe PMC (PubMed Central)', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1303153112', 'host_organization_name': 'European Bioinformatics Institute', 'host_organization_lineage': ['https://openalex.org/I1303153112'], 'host_organization_lineage_names': ['European Bioinformatics Institute'], 'type': 'repository'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': True, 'landing_page_url': 'https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6585631', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S2764455111', 'display_name': 'PubMed Central', 'issn_l': None, 'issn': None, 'is_oa': True, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30239982', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1111/bjh.15566', 'pdf_url': 'https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bjh.15566', 'source': {'id': 'https://openalex.org/S153015021', 'display_name': 'British Journal of Haematology', 'issn_l': '0007-1048', 'issn': ['0007-1048', '1365-2141'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320595', 'host_organization_name': 'Wiley', 'host_organization_lineage': ['https://openalex.org/P4310320595'], 'host_organization_lineage_names': ['Wiley'], 'type': 'journal'}, 'license': 'cc-by-nc', 'license_id': 'https://openalex.org/licenses/cc-by-nc', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.66, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 20, 'referenced_works': ['https://openalex.org/W1973535185', 'https://openalex.org/W1978054534', 'https://openalex.org/W2065778093', 'https://openalex.org/W2084450115', 'https://openalex.org/W2133487516', 'https://openalex.org/W2146701863', 'https://openalex.org/W2158830277', 'https://openalex.org/W2168678052', 'https://openalex.org/W2211631799', 'https://openalex.org/W2342440786', 'https://openalex.org/W2469052042', 'https://openalex.org/W2498753998', 'https://openalex.org/W2515183449', 'https://openalex.org/W2526662567', 'https://openalex.org/W2765462510', 'https://openalex.org/W2767770931', 'https://openalex.org/W3016442292', 'https://openalex.org/W3157311495', 'https://openalex.org/W4210505887', 'https://openalex.org/W4236235343'], 'related_works': ['https://openalex.org/W4361953471', 'https://openalex.org/W4306641990', 'https://openalex.org/W2991931587', 'https://openalex.org/W2897997055', 'https://openalex.org/W2893570865', 'https://openalex.org/W2891879965', 'https://openalex.org/W2789382755', 'https://openalex.org/W2171380046', 'https://openalex.org/W2058793701', 'https://openalex.org/W1827095708'], 'abstract_inverted_index': {'Summary': [0], 'First‐line': [1], 'treatments': [2], 'for': [3, 69, 168, 182, 240], 'classical': [4], 'Hodgkin': [5], 'lymphoma': [6], '(': [7, 48, 81, 102, 108, 124, 129], 'HL': [8, 100], ')': [9, 50], 'include': [10], 'ABVD': [11, 38, 73], '(adriamycin,': [12], 'bleomycin,': [13, 21], 'vinblastine,': [14], 'dacarbazine)': [15, 87], 'and': [16, 37, 77, 86, 90, 106, 115, 132, 140, 149, 165, 188], 'BEACOPP': [17, 40, 75], 'escalated': [18, 76], '(escalated': [19], 'dose': [20], 'etoposide,': [22], 'adriamycin,': [23, 84], 'cyclophosphamide,': [24], 'vincristine,': [25], 'procarbazine,': [26], 'prednisone).': [27], 'To': [28], 'further': [29], 'improve': [30], 'overall': [31, 127], 'outcomes,': [32], 'positron': [33], 'emission': [34], 'tomography‐driven': [35], 'strategies': [36], 'or': [39, 51, 205], 'variants': [41], 'incorporating': [42], 'the': [43, 116, 133, 152, 159, 176, 179, 234], 'antibody‐drug': [44], 'conjugate': [45], 'brentuximab': [46], 'vedotin': [47], 'BV': [49, 78, 82], 'anti‐': [52], 'PD': [53], '1': [54], 'antibodies': [55], 'are': [56], 'under': [57], 'investigation': [58], 'in': [59, 112, 237], 'advanced‐stage': [60], 'patients.': [61, 208, 242], 'The': [62], 'present': [63], 'study': [64], 'aimed': [65], 'to': [66, 99, 143, 157, 175, 213, 230], 'elicit': [67], 'preferences': [68], 'attributes': [70, 120, 156], 'associated': [71], 'with': [72, 223], ',': [74, 83], '‐': [79], 'AVD': [80], 'vinblastine': [85], 'among': [88, 172], 'patients': [89, 101, 199], 'physicians.': [91], 'Cross‐sectional': [92], 'online': [93], 'discrete': [94], 'choice': [95], 'experiments': [96], 'were': [97, 121, 151], 'administered': [98], 'n': [103, 109], '=': [104, 110], '381)': [105], 'haematologists/oncologists': [107], '357)': [111], 'France,': [113], 'Germany': [114], 'United': [117], 'Kingdom.': [118], 'Included': [119], 'progression‐free': [122], 'survival': [123, 128], 'PFS': [125, 148, 187, 218], '),': [126, 131], 'OS': [130, 150, 189], 'risk': [134], 'of': [135, 162, 178], 'neuropathy,': [136], 'lung': [137], 'damage,': [138], 'infertility': [139], 'hospitalisation': [141], 'due': [142, 229], 'adverse': [144, 231], 'events.': [145], 'Whereas': [146], '5‐year': [147], 'most': [153, 190], 'important': [154, 212], 'treatment': [155, 184, 215, 238], 'patients,': [158], 'relative': [160], 'importance': [161], 'each': [163, 169], 'attribute': [164], 'preference': [166], 'weights': [167], 'level': [170], 'varied': [171], 'physicians': [173], 'according': [174], 'description': [177], 'hypothetical': [180], 'patient': [181], 'whom': [183], 'was': [185, 210], 'recommended.': [186], 'strongly': [191], 'influenced': [192], 'physicians’': [193, 214], 'recommendations': [194], 'when': [195, 219], 'considering': [196, 220], 'young': [197, 206, 221], 'female': [198], 'who': [200], 'did': [201], 'not': [202], 'want': [203], 'children': [204], 'male': [207], 'Infertility': [209], 'more': [211], 'decision': [216], 'than': [217], 'women': [222], 'unknown': [224], 'fertility': [225], 'preferences,': [226], 'whereas': [227], 'hospitalisations': [228], 'events': [232], 'played': [233], 'largest': [235], 'role': [236], 'decisions': [239], 'older': [241]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2893570865', 'counts_by_year': [{'year': 2024, 'cited_by_count': 4}, {'year': 2023, 'cited_by_count': 10}, {'year': 2022, 'cited_by_count': 10}, {'year': 2021, 'cited_by_count': 8}, {'year': 2020, 'cited_by_count': 9}, {'year': 2019, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 1}], 'updated_date': '2024-12-24T15:46:46.521471', 'created_date': '2018-10-05'}